BBIO- Bridgebio Pharma, Inc.

Name: Bridgebio Pharma, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Bridgebio Pharma, Inc. (BBIO) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 40 sells. BBIO is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
?	Viking Global Investors LP	18.56M	$1.23B	-
10%	Bridgebio Pharma LLC	14.59M	$966.87M	-
CEO	Kumar Neil	4.40M	$291.49M	-
Dir	Homcy Charles J	916.7K	$60.75M	-
Dir	McCormick Frank	766.6K	$50.80M	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 17, 2025	Trimarchi Thomas	President And CFO	Sell	16,934	$66.46	$1,125,404.42	-2.1%	+13.4%	-
Nov 12, 2025	Valantine Hannah53	Director	Sale+OE	25,484	$66.07	$1,683,727.88	-77.3%	+9.4%	-
Nov 7, 2025	Kumar Neil	Chief Executive Officer	Sell	80,000	$62.29	$4,983,111.08	-0.2%	+3.1%	-
Nov 6, 2025	Daniels Ronald J	Director	Sale+OE	61,031	$63.72	$3,888,999.07	-78.2%	+19.9%	-
Oct 29, 2025	McCormick Frank61	Director	Sell	198,359	$66.58	$13,206,527.70	-5.2%	+16.9%	-
Oct 27, 2025	McCormick Frank61	Director	Sell	1,641	$65.00	$106,665.00	-0.2%	+22.4%	-
Oct 9, 2025	Kumar Neil	Chief Executive Officer	Sell	80,000	$54.79	$4,383,442.21	-0.5%	+35.6%	-
Sep 5, 2025	McCormick Frank61	Director	Sale+OE	74,000	$53.16	$3,933,544.00	-47.1%	+40.1%	-
Sep 5, 2025	Kumar Neil	Chief Executive Officer	Sell	80,000	$52.20	$4,175,835.24	-0.3%	+40.1%	-
Aug 21, 2025	Trimarchi Thomas	President And CFO	Sell	42,237	$49.48	$2,090,081.05	-9.1%	+30.5%	-

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC